Tocqueville Asset Management L.P. Esperion Therapeutics, Inc. Transaction History
Tocqueville Asset Management L.P.
- $6.38 Billion
- Q2 2025
A detailed history of Tocqueville Asset Management L.P. transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Tocqueville Asset Management L.P. holds 63,500 shares of ESPR stock, worth $175,895. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,500
Previous 65,000
2.31%
Holding current value
$175,895
Previous $93,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ESPR
# of Institutions
183Shares Held
106MCall Options Held
139KPut Options Held
604K-
Black Rock Inc. New York, NY14MShares$38.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$32.5 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT10.3MShares$28.6 Million0.05% of portfolio
-
Two Seas Capital LP Rye, NY9.95MShares$27.6 Million0.18% of portfolio
-
Pender Fund Capital Management Ltd. Vancouver, A16.68MShares$18.5 Million4.26% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $184M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...